HALOZYME THERAPEUTICS INC

CUSIP: 40637HAD1 Class: NOTE 0.250% 3/0

Wellesley Asset Management's Holding History (CIK: 0001533551)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 23,374,000 Value ($000) $27,309 Avg Close — Range —
Q2 2025
Shares 25,991,000 Value ($000) $25,964 Avg Close — Range —
Q1 2025
Shares 30,899,000 Value ($000) $32,337 Avg Close — Range —
Q4 2024
Shares 48,602,000 Value ($000) $46,434 Avg Close — Range —
Q3 2024
Shares 48,263,000 Value ($000) $48,426 Avg Close — Range —
Q2 2024
Shares 50,814,415 Value ($000) $48,642 Avg Close — Range —
Q1 2024
Shares 54,336,000 Value ($000) $48,210 Avg Close — Range —
Q4 2023
Shares 60,995,220 Value ($000) $53,210 Avg Close — Range —
Q3 2023
Shares 64,339,813 Value ($000) $55,234 Avg Close — Range —
Q2 2023
Shares 59,699,359 Value ($000) $50,185 Avg Close — Range —
Q1 2023
Shares 70,776,482 Value ($000) $60,421 Avg Close — Range —
Q4 2022
Shares 77,437 Value ($000) $75 Avg Close — Range —
Q3 2022
Shares 89,152 Value ($000) $76,268 Avg Close — Range —
Q2 2022
Shares 92,289 Value ($000) $82,027 Avg Close — Range —
Q1 2022
Shares 71,432 Value ($000) $63,617 Avg Close — Range —